FREDERICTON (GNB) – The provincial program to provide universal access to Mifegymiso is now operational and available to New Brunswickers.

Mifegymiso, commonly referred to as the abortion pill, is a combination drug product approved for the medical termination of a pregnancy up to 49 days. It was authorized by Health Canada in July 2015 and became available on the market in January.

“Your government knows that access to reproductive health services is important to New Brunswickers,” said Health Minister Victor Boudreau. “We are proud to be the first Canadian province to create a program that provides universal access to Mifegymiso.”

The program ensures that any patient with a valid Medicare card is eligible to receive Mifegymiso free of charge. More information about the program is available online.

“Action Canada for Sexual Health and Rights is thrilled that New Brunswick has taken leadership in becoming the first province to implement cost coverage for Mifegymiso,” said Frédérique Chabot, the organization’s health information officer. “Making medical abortion more easily available is an important way to expand both choice and access. For people in remote and rural areas, this could be a game changer. Almost three decades have passed since abortion was decriminalized in Canada but those who wish to access this medical service often still face many roadblocks. This is of great concern as abortion is a common procedure and an integral part of a comprehensive package of reproductive health-care services.”

“Your government has eliminated barriers to reproductive health that were in place for three decades, and is committed to doing more,” said Boudreau. “By making Mifegymiso available free of charge for all New Brunswick patients, we are ensuring that financial barriers do not stand in the way of New Brunswickers’ right to choose.”